<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151501">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02091089</url>
  </required_header>
  <id_info>
    <org_study_id>CYN13-PICO-LENS-RW</org_study_id>
    <nct_id>NCT02091089</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles</brief_title>
  <official_title>Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of the treatment of
      wrinkles using the picosecond 755nm Alexandrite laser.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Photographic Evaluation of wrinkle severity</measure>
    <time_frame>up to 6 months post last treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reporting of adverse events</measure>
    <time_frame>up to 6 months post last treatment</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Wrinkles</condition>
  <arm_group>
    <arm_group_label>755nm Alexandrite laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>755nm Alexandrite laser for the treatment of wrinkles</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>755nm Alexandrite laser</intervention_name>
    <description>755nm Alexandrite laser for the treatment of wrinkles</description>
    <arm_group_label>755nm Alexandrite laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Is a healthy non-smoking (must have quit 1 year prior) male or female between    18
             and 65 years old.

          2. Is willing to consent to participate in the study.

          3. Is willing to comply with all requirements of the study including biopsies, being
             photographed, following post treatment care and attending all treatment and follow up
             visits.

        Exclusion Criteria:

          1. The subject is female and pregnant, has been pregnant within the last 3 months, is
             currently breast feeding or planning a pregnancy during the study period.

          2. The subject is hypersensitive to light exposure OR takes photo sensitized medication.

          3. The subject has active or localized systemic infections.

          4. The subject has a coagulation disorder or is currently using anti-coagulation
             medication (including but not limited to heavy aspirin therapy {greater than 81 mg
             per day}).

          5. The subject has any condition which, in the investigator's opinion, would make it
             unsafe for the subject to participate in this research study.

          6. The subject is currently enrolled in an investigational drug or device trial, or has
             received an investigational drug or been treated with an investigational device
             within 3 months prior to entering this study.

          7. The subject has used Accutane within 6 months prior to enrollment.

          8. The subject has the need to be exposed to artificial tanning devices or excessive
             sunlight during the trial.

          9. The subject has had prior treatment with parenteral gold therapy (gold sodium
             thiomalate).

         10. The subject has a history of keloids.

         11. The subject has evidence of compromised wound healing.

         12. The subject has a history of squamous cell carcinoma or melanoma.

         13. The subject has a history of immunosuppression/immune deficiency disorders (including
             HIV infection or AIDS) or use of immunosuppressive medications.

         14. The subject has an allergy to lidocaine and epinephrine.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maryland Laser, Skin and Vein Institute</name>
      <address>
        <city>Hunt Valley</city>
        <state>Maryland</state>
        <zip>21030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 17, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
